Lercanidipine Hydrochloride Amarox

Lercanidipine hydrochloride, the active ingredient in Lercanidipine Hydrochloride Amarox, is a dihydropyridine calcium channel blocker presented as a tablet for oral use. It treats hypertension in adult patients. GNH USA supplies Lercanidipine Hydrochloride Amarox as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lercanidipine hydrochloride is a dihydropyridine calcium channel blocker used to manage elevated arterial pressure.

Hypertension: lowers systolic and diastolic blood pressure and reduces cardiovascular risk. Essential hypertension: provides sustained blood pressure control in primary hypertension. Isolated systolic hypertension: improves pulse pressure in elderly patients with elevated systolic values.

Lercanidipine may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild to moderate intensity, often transient. - Flushing: warmth and redness, usually resolves with continued therapy. - Peripheral edema: swelling of ankles or lower legs. - Dizziness or light‑headedness, especially after standing. - Palpitations or tachycardia.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Myocardial infarction: rare but reported in susceptible individuals. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Angioedema: swelling of face, lips, or throat. - Severe allergic reactions: rash, itching, or anaphylaxis.

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential complications.

Monitor blood pressure: adjust dose based on response and avoid excessive hypotension. Assess liver function: use with caution in patients with hepatic impairment. Caution in elderly: increased sensitivity to vasodilatory effects may occur. Avoid abrupt discontinuation: tapering may reduce rebound hypertension. Use with caution in heart failure: monitor for fluid retention. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lercanidipine can interact with several drug classes, influencing its efficacy and safety.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may increase plasma levels. - CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce effectiveness. - Grapefruit juice: can markedly raise drug concentrations. - Concurrent use with other potent antihypertensives: risk of additive hypotension. - Nitrates: may cause severe vasodilation.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt compensatory heart rate response. - Diuretics: enhance blood pressure‑lowering effect. - Other calcium channel blockers: potential additive vasodilatory effect. - NSAIDs: may attenuate antihypertensive response. - Antidiabetic agents: monitor glucose as blood pressure changes can affect glycemic control.